Resources

Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C

Showing 1 to 10 of 311 resources

  • Summary report: Hepatitis C in the justice system - going beyond prisons
    This report summarises the presentations and discussions from the HCV Action webinar, 'Hepatitis C in the justice system - going beyond prisons', held on Friday 23rd October as part of the National Hepatitis C ODN Stakeholder Webinar series. The event focused in particular on providing support around hepatitis C for those making the transition from prison to the community.
    UK 17 Nov 2020 Reports & Research, Tools & Templates, Strategy & Planning PDF
  • Summary report: National Hepatitis C ODN Stakeholder Event 2020
    Eighteen months on from the start of NHS England’s hepatitis C elimination deal, HCV Action’s annual ODN event, co-hosted with the British Viral Hepatitis Group, explored how the UK has progressed towards elimination. It particularly focused on overcoming the challenges posed by the significant disruption of Covid-19 on healthcare services. This year’s event was held as a half-day webinar due to coronavirus-related restrictions and welcomed 129 participants from almost all ODNs and partner services.
    England 30 Oct 2020 Reports & Research, Tools & Templates, Strategy & Planning PDF
  • Summary report: Mitigating the impact of COVID-19 on HCV testing
    This is the written summary of a webinar held on 8th October on mitigating the impact of COVID-19 on HCV testing. The first part of the webinar consisted of three presentations: Overview of testing, before and after COVID-19 - Helen Hampton, Lead Clinical Nurse for Blood Borne Virus, We Are With You; Outreach testing during the COVID-19 lockdown - Julian Surey, Find and Treat Team; and Postal testing or self-testing - Tracey Kemp, National Hepatitis C Strategy Lead, Change Grow Live
    UK, England 30 Oct 2020 Case study, Tools & Templates, Strategy & Planning PDF
  • Workshop webinar: Hepatitis C in the justice system - going beyond prisons
    This is a recording of a webinar covering initiatives to test and treat people for hepatitis C in contact with the justice system in England, held on the 23rd October 2020. Previous events and initiatives in this area have aimed to support people in prisons. Whilst this is important and continues, this webinar focused on new initiatives for people in contact with other areas of the justice system, such as probation services. The webinar featured 3 talks:
    North East, UK 29 Oct 2020 Case study, Strategy & Planning Video
  • Webinar: Mitigating the impact of COVID-19 on hepatitis C testing
    This is a recording of a webinar focusing on how services can mitigate the impact of COVID-19 on hepatitis C testing and find alternative ways to test people. The first part of the webinar consisted of three presentations: 1/ Overview of testing, before and after COVID-19 - Helen Hampton, Lead Clinical Nurse for Blood Borne Virus, We Are With You 2/ Outreach testing during the COVID-19 lockdown - Julian Surey, Find and Treat Team 3/ Postal testing or self-testing - Tracey Kemp, National Hepatitis C Strategy Lead, Change Grow Live
    UK 22 Oct 2020 Case study, Tools & Templates, Strategy & Planning Video
  • Webinar: Under-served groups for hepatitis C testing and treatment
    This webinar sought to look at how services can provide hepatitis C testing and treatment to people who have been traditionally under-served by health services. This workshop sought to discuss: - Sex workers - Gypsy, Roma and Traveller people - South Asian communities - Migrants For each of these groups, this video features a presentation exploring the general barriers to healthcare that they face and examples of projects which have improved access to healthcare for them along with a Q&A session at the end.
    UK 22 Oct 2020 Case study, Training, Strategy & Planning Video
  • Summary report: Hepatitis C case-finding in under-served groups - October 2020
    This report summarises the October 2020 HCV Action webinar on hepatitis C case-finding in under-served groups, which formed part of a week-long series of webinars centred around the National Hepatitis C ODN Stakeholder Event. The webinar focused on four under-served groups in particular: Gypsy, Roma and Travellers; migrants; sex-workers, and the South Asian community. The webinar featured contributions from the following speakers: • Beth Davies – Head of Service and Development (Dorset), EDP Drug & Alcohol Services • Dr Inês Campos-Matos – Head of Migration Health, Public Health England
    UK 22 Oct 2020 Reports & Research PDF
  • HCV Action ODN Stakeholder Event 2020: A national perspective on elimination
    These are the opening talks from this year's ODN Stakeholder Event from Mark Gillyon-Powell, Head of Programme for HCV Elimination, NHS England and Prof Graham Foster, National Clinical Lead for ODNs, NHS England. The talks gives a national overview on hepatitis C elimination efforts in England and how COVID-19 has impacted these. Professor Guruprasad Aithal, President of the British Association for the Study of the Liver (BASL) chaired the event. We will be publishing a written summary of the other presentations from this event soon.
    England 07 Oct 2020 Other, Strategy & Planning Video
  • A glossary of contested terms in substance use
    This is a glossary of terms used by people working in the drugs field, drawn up by the Scottish Drugs Forum. It covers some of the specialised and contentious language used in the field. We have included it in the resource library as it may be helpful to those who work in health services who are less familiar with some of the language and terms used by colleagues and partners in drug services.
    UK 07 Oct 2020 Training, Reports & Research PDF
  • Unlinked Anonymous Monitoring (UAM) Survey of HIV and viral hepatitis among PWID: 2020 report
    The 2020 edition of the Unlinked Anonymous Monitoring (UAM) Survey of HIV and viral hepatitis among PWID contains a number of relevant updates on hepatitis C among injecting drug users, including: • The proportion of UAM participants with antibodies to hepatitis C (HCV) (i.e. ever infected) who have markers of chronic infection (RNA) has decreased from 58% in 2011 when it was first measured to 42% in 2019; this corresponds with the timing of the scale-up of direct acting antiviral treatment against HCV among PWID
    UK 06 Oct 2020 Reports & Research PDF

Pages